Carregant...
Tipus de document
ArticleData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/227672
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Background & Aims: Baveno VII has defined a clinically significant ( i.e. , prognostically meaningful) decrease in liver stiffness measurement (LSM) in cACLD as a decrease of >-20% associated with a final LSM -20 kPa. After HCV cure, FU-LSM decreased to a median of 10.9 kPa (-20 kPa: 465 [19.9%]) translating into a median LSM change of-5.3 (-8.8 to-2.4) kPa corresponding to-33.9 (-48.0 to-15.9) %. Patients achieving a clinically significant decrease (65.4%) had a significantly lower risk of hepatic decompensation (subdistribution hazard ratio: 0.12, 95% CI 0.04-0.35, p -20% (p p = 0.550). Conclusions: FU-LSM is key for risk stratification after HCV cure and should guide clinical decision making. LSM dynamics do not hold significant prognostic information in patients with FU-LSM 10-19.9 kPa, and thus, their consideration is not of sufficient incremental value in the specific context of HCV cure. (c) 2024 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Matèries
Matèries (anglès)
Citació
Citació
Semmler G, LOPEZ, Sa, PONS, M, LENS GARCÍA, Sabela, DAJTI, E, GRIEMSMANN, M, ZANETTO, A, BURGHART, L, HAMETNER-SCHREIL, S, HARTL, L, MANZANO, M, RODRÍGUEZ TAJES, Sergio, ZANAGA, P, SCHWARZ, M, GUTIERREZ, Ml, JACHS, M, POCURULL APARICIO, Anna, POLO, B, ECKER, D, MATEOS, B, IZQUIERDO, S, REAL, Y, AHUMADA, A, BAUER, Djm, MAUZ, Jb, CASANOVA-CABRAL, M, GSCHWANTLER, M, RUSSO, Fp, AZZAROLI, F, MAASOUMY, B, REIBERGER, T, FORNS BERNHARDT, Xavier, GENESCA, J, BANARES, R, Mandorfer M. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure. _Journal Of Hepatology_. 2024. Vol. 81, núm. 1, pàgs. 76-83. [consulta: 28 de febrer de 2026]. ISSN: Semmler, Georg; Lopez, Sonia Alonso; Pons, Monica; Lens, Sabela; Dajti, Elton; Griemsmann, Marie; Zanetto, Alberto; Burghart, Lukas; Hametner-Schreil, (2024). Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure. Journal Of Hepatology, 81(1), 76-83. DOI: 10.1016/j.jhep.2024.03.015. [Disponible a: https://hdl.handle.net/2445/227672]